Terug
Dagbereik
€ 7,63
€ 7,78
52-Weeksbereik
€ 6,19
€ 11,14
Volume
718.428
50D / 200D Gem.
€ 8,93
/
€ 9,32
Vorige Slotkoers
€ 7,58
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (626 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 16,9 | 0,4 |
| P/B | 1,2 | 2,9 |
| ROE % | 6,9 | 3,8 |
| Net Margin % | 5,3 | 3,9 |
| Rev Growth 5Y % | 10,0 | 10,0 |
| D/E | 1,7 | 0,2 |
Belangrijkste Punten
Revenue grew 10,02% annually over 5 years — strong growth
Earnings grew 146,07% over the past year
Generating 751,14M in free cash flow
PEG of 0,09 suggests growth is underpriced
Revenue growth is decelerating — 1Y growth trails 5Y average by 9,82%
Cash machine — converts 194,53% of earnings into free cash flow
Groei
Revenue Growth (5Y)
10,02%
Revenue (1Y)0,20%
Earnings (1Y)146,07%
FCF Growth (3Y)N/A
Kwaliteit
Return on Equity
6,92%
ROIC6,36%
Net Margin5,34%
Op. Margin16,43%
Veiligheid
Debt / Equity
1,66
Current Ratio2,51
Interest Coverage1,98
Waardering
P/E Ratio
16,85
P/B Ratio1,23
EV/EBITDA12,15
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 0,20% | Revenue Growth (3Y) | 4,71% |
| Earnings Growth (1Y) | 146,07% | Earnings Growth (3Y) | 202,07% |
| Revenue Growth (5Y) | 10,02% | Earnings Growth (5Y) | 19,60% |
| Profitability | |||
| Revenue (TTM) | 7,23B | Net Income (TTM) | 386,13M |
| ROE | 6,92% | ROA | 1,96% |
| Gross Margin | 35,70% | Operating Margin | 16,43% |
| Net Margin | 5,34% | Free Cash Flow (TTM) | 751,14M |
| ROIC | 6,36% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | 1,66 | Current Ratio | 2,51 |
| Interest Coverage | 1,98 | Dividend Yield | 0,02% |
| Valuation | |||
| P/E Ratio | 16,85 | P/B Ratio | 1,23 |
| P/S Ratio | 0,90 | PEG Ratio | 0,09 |
| EV/EBITDA | 12,15 | Dividend Yield | 0,02% |
| Market Cap | 6,51B | Enterprise Value | 14,42B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 7,23B | 7,21B | 6,59B | 6,06B | 4,93B |
| Net Income | 386,13M | 156,92M | 42,32M | 185,04M | 188,73M |
| EPS (Diluted) | 0,57 | 0,23 | 0,09 | 0,31 | 0,27 |
| Gross Profit | 2,58B | 2,79B | 2,48B | 2,21B | 1,96B |
| Operating Income | 1,19B | 1,19B | 782,32M | 782,44M | 595,06M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 19,75B | 21,41B | 20,99B | 21,23B | 19,23B |
| Total Liabilities | 12,13B | 12,80B | 13,48B | 13,25B | 11,92B |
| Shareholders' Equity | 5,27B | 5,88B | 5,37B | 5,65B | 5,52B |
| Total Debt | 8,74B | 10,09B | 11,02B | 9,75B | 10,17B |
| Cash & Equivalents | 824,65M | 979,78M | 529,58M | 549,21M | 655,49M |
| Current Assets | 5,07B | 5,73B | 6,13B | 4,69B | 5,51B |
| Current Liabilities | 2,02B | 2,16B | 2,33B | 2,02B | 3,47B |